PepGen Inc.

PEPG

PepGen Inc.

PEPG

Insider Sentiment (TTM):

Last Purchase:2025-09-30Last Sale:2026-05-21Shares Purchased (TTM):9,575,000Shares Sold (TTM):10,471

Institutional Sentiment:

As of:2026-03-31Institutional Shares Owned:55,405,578Shares Outstanding:69,091,100Institutional Ownership Pct.:80.19%

Earnings Market Reaction:

Filing Date:2026-08-06Price on Filing Date:N/APrevious Close:N/A% Change:N/A

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Financial Statements

10‑Q10‑K

Values in Millions ($)	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Assets
Cash And Cash Equivalents At Carrying Value	23	42	61	143	35	44	49	42	66	134	81	130
Marketable Securities Current	94	90	88	21	40	54	71	97	95	41	30	-
Assets Current
Assets Current	120	134	151	166	77	101	124	142	165	178	113	133
Prepaid Expense And Other Assets Current	3	2	3	3	3	3	4	4	3	2	2	4
Property Plant And Equipment Net	1	2	2	2	2	4	4	4	4	4	5	5
Operating Lease Right Of Use Asset	18	19	19	20	20	21	21	22	23	23	24	24
Restricted Cash Noncurrent	2	2	2	2	2	2	2	2	-	-	2	-
Other Assets Noncurrent	0	0	0	0	0	0	0	0	2	2	2	2
Assets	141	156	174	190	102	127	151	170	194	207	143	164
Liabilities And Stockhold…
Accounts Payable Current	1	1	1	1	1	3	2	6	8	1	1	4
Liabilities Current
Accrued Liabilities Current	5	5	9	9	12	15	12	8	11	7	14	14
Liabilities Current	9	9	13	13	16	20	17	17	22	11	18	21
Operating Lease Liability Current	3	3	3	3	3	3	3	3	3	3	3	3
Operating Lease Liability Noncurrent	13	13	14	14	15	15	16	16	16	17	17	17
Liabilities	22	22	26	27	31	36	32	33	38	28	35	38
Temporary Equity
Common Stock Value	0	0	0	0	0	0	0	0	0	0	0	0
Additional Paid In Capital Common Stock	516	513	509	506	396	393	390	387	383	379	290	288
Stockholders Equity
Stockholders Equity	120	134	147	163	71	92	119	137	155	179	108	126
Accumulated Other Comprehensive Income Loss Net Of…	-0	-0	0	-0	-0	-0	0	0	-0	-0	0	-0
Retained Earnings Accumulated Deficit	-397	-379	-361	-343	-325	-302	-271	-249	-228	-200	-181	-162
Liabilities And Stockholders Equity	141	156	174	190	102	127	151	170	194	207	143	164
Preferred Stock Par Or Stated Value Per Share	-	-	0	-	-	-	0	-	-	-	0	-
Preferred Stock Shares Authorized	-	-	10	-	-	-	10	-	-	-	10	-
Common Stock Par Or Stated Value Per Share	-	-	0	-	-	-	0	-	-	-	0	-
Common Stock Shares Authorized	-	-	500	-	-	-	500	-	-	-	500	-
Common Stock Shares Issued	-	-	69	-	-	-	33	-	-	-	24	-
Shares Outstanding	-	-	69	-	-	-	33	-	-	-	24	-

Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Start free trial

Custom Table

10‑Q10‑K

0/5

Search a metric to start building a table

Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Start free trial

Interactive Financial Visualizations

10‑Q10‑K

Stock Price:

OnOff

Transformations:

0/1

Search a metric to start building a visual

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Earnings Market Reaction

10‑Q10‑K

Fiscal Year	Q1 1 Month	Q1 2 Month	Q1 3 Month	Q2 1 Month	Q2 2 Month	Q2 3 Month	Q3 1 Month	Q3 2 Month	Q3 3 Month	Q4 1 Month	Q4 2 Month	Q4 3 Month
2026	-16.07%	4.76%	4.76%	-	-	-	-	-	-	-	-	-
2025	-5.19%	-25.32%	-5.84%	-2.52%	326.05%	284.03%	6.04%	39.77%	0.00%	-33.14%	-77.22%	-77.66%
2024	18.44%	20.37%	-29.88%	7.24%	-1.78%	-14.48%	-10.30%	-30.37%	-65.54%	-22.71%	-41.92%	-32.75%
2023	-	-	-	25.93%	-0.97%	6.04%	19.87%	51.79%	53.13%	-4.61%	-22.58%	-5.52%
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial

Subscribe to unlock 17+ years of financial data and 90+ calculated metrics

Start 7-day free trial

Subscribe to unlock 17+ years of data and 90+ calculated metrics

Start free trial

Performance and Valuation Metrics

Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.

Metrics	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Liquidity Ratios
Current Ratio	13.36	14.98	11.94	13.15	4.74	4.95	7.41	8.47	7.45	15.78	6.43	6.35
Quick Ratio	13.02	14.76	11.74	12.95	4.56	4.79	7.20	8.26	7.30	15.56	6.30	6.18
Working Capital	111.32M	125.31M	138.32M	153.56M	61.13M	80.62M	107.07M	125.56M	142.67M	166.36M	95.15M	112.14M
Leverage & Debt
Debt to Equity	0.18	0.17	0.18	0.16	0.44	0.39	0.27	0.24	0.25	0.16	0.32	0.31
Debt Ratio	0.15	0.14	0.15	0.14	0.30	0.28	0.21	0.19	0.20	0.14	0.24	0.23
Efficiency & Turnover
Asset Turnover TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Per Share Metrics
Diluted EPS TTM	-1.04	-1.12	-2.12	-2.72	-2.96	-3.13	-2.85	-2.68	-2.75	-2.80	-3.30	-3.11
Free Cash Flow Per Share TTM	-1.07	-1.12	-1.94	-1.83	-2.07	-2.55	-2.62	-2.54	-2.32	-2.71	-3.01	-2.79
Dividend Per Share TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Growth Metrics
Net Income Growth (1Y)	-25.77%	-24.42%	-0.36%	7.25%	8.72%	27.18%	14.44%	17.78%	28.47%	19.58%	13.78%	-
EPS Growth (1Y)	-64.87%	-64.26%	-25.47%	1.69%	7.79%	11.54%	-13.77%	-14.00%	-5.87%	-0.85%	-25.22%	-
Valuation Metrics
P/E TTM	-1.73	-1.58	-3.07	-1.70	-0.38	-0.45	-1.33	-3.19	-5.81	-5.24	-2.06	-1.63
P/B TTM	1.04	0.91	1.86	0.97	0.51	0.50	1.01	2.03	3.34	2.35	1.49	0.96
Market Cap	124.56M	122.29M	274.86M	158.76M	36.35M	45.91M	119.70M	278.57M	518.21M	421.25M	161.81M	120.86M
Enterprise Value	101.80M	80.14M	214.35M	15.98M	1.28M	2.27M	70.28M	236.28M	452.12M	287.40M	81.04M	-8.68M
Calculated Values
Free Cash Flow TTM	-74.09M	-77.43M	-82.06M	-62.87M	-67.71M	-83.34M	-82.87M	-82.77M	-75.49M	-77.58M	-71.60M	-66.48M
Net Debt	-22.76M	-42.15M	-60.51M	-142.78M	-35.07M	-43.63M	-49.42M	-42.29M	-66.09M	-133.85M	-80.77M	-129.54M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
NCAV
NCAV Per Share TTM
Valuation Ratios
P/CF TTM
PEG Ratio
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
EV Revenue TTM
EV FCF TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Insider Transactions

2026-05-21Sale

Owner: Kasraian, Kasra

Title: Chief Technical Officer

Shares: 1,233

Price/Share: $1.41

Value: $1,738.53

Shares Owned: 50,074

Relationship: Officer

Ownership: Direct

2026-03-04Sale

Owner: Streck, Paul

Title: EVP, Head of R&D

Shares: 1,879

Price/Share: $6.26

Value: $11,762.54

Shares Owned: 76,226

Relationship: Officer

Ownership: Direct

2026-03-04Sale

Owner: Mcarthur, James G

Title: President and CEO

Shares: 5,275

Price/Share: $6.28

Value: $33,127.00

Shares Owned: 296,326

Relationship: Director,Officer

Ownership: Direct

2026-03-04Sale

Owner: Donnelly, Noel

Title: Chief Financial Officer

Shares: 2,084

Price/Share: $6.28

Value: $13,087.52

Shares Owned: 111,603

Relationship: Officer

Ownership: Direct

2025-09-30Purchase

Owner: Oxford, Science Enterpris…

Title: -

Shares: 200,000

Price/Share: $3.20

Value: $640,000.00

Shares Owned: 4,955,388

Relationship: Other

Ownership: Direct

Filed Date	Owner	Relationship	Title	Ownership	Purchase/Sale	No. Shares	Price Per Share	Value	Shares Owned	Document Type
2026-05-21	Kasraian, Kasra	Officer	Chief Technical Officer	Direct	Sale	1,233	1.41	$1,738.53	50,074	4
2026-03-04	Streck, Paul	Officer	EVP, Head of R&D	Direct	Sale	1,879	6.26	$11,762.54	76,226	4
2026-03-04	Mcarthur, James G	Director,Officer	President and CEO	Direct	Sale	5,275	6.28	$33,127.00	296,326	4
2026-03-04	Donnelly, Noel	Officer	Chief Financial Officer	Direct	Sale	2,084	6.28	$13,087.52	111,603	4
2025-09-30	Oxford, Science Enterpris…	Other	-	Direct	Purchase	200,000	3.20	$640,000.00	4,955,388	4
2025-09-26	Ra, Capital Healthcare Fu…	Director,TenPercentOwner	-	Indirect	Purchase	9,375,000	3.20	$30,000,000.00	18,554,273	4
2025-05-30	Streck, Paul	Officer	EVP, Head of R&D	Direct	Purchase	8,375	1.24	$10,385.00	27,805	4
2025-04-17	Mcarthur, James G	Director,Officer	President and CEO	Direct	Purchase	10,000	1.36	$13,600.00	113,913	4
2025-04-08	Mcarthur, James G	Director,Officer	President and CEO	Direct	Purchase	41,500	1.15	$47,725.00	103,913	4
2025-02-26	Donnelly, Noel	Officer	Chief Financial Officer	Direct	Sale	1,527	1.68	$2,565.36	1,673	4
2025-02-26	Delena, Mary Beth	Officer	General Counsel	Direct	Sale	1,432	1.68	$2,405.76	1,568	4
2024-07-25	Mellion, Michelle L	Officer	Chief Medical Officer	Direct	Sale	7,571	18.06	$136,732.26	0	4
2024-07-18	Mellion, Michelle L	Officer	Chief Medical Officer	Direct	Sale	12,625	18.20	$229,775.00	0	4
2024-07-16	Mellion, Michelle L	Officer	Chief Medical Officer	Direct	Sale	5,901	18.00	$106,218.00	0	4
2024-07-02	Mellion, Michelle L	Officer	Chief Medical Officer	Direct	Sale	37	18.07	$668.59	0	4
2024-06-24	Mellion, Michelle L	Officer	Chief Medical Officer	Direct	Sale	9,260	18.19	$168,439.40	0	4
2024-06-12	Mellion, Michelle L	Officer	Chief Medical Officer	Direct	Sale	1,086	18.06	$19,613.16	0	4
2024-06-06	Mellion, Michelle L	Officer	SVP, Clinical Development	Direct	Sale	1,411	18.00	$25,398.00	0	4
2024-05-17	Svenstrup, Niels	Officer	SVP, Chem. Mfg & Controls	Direct	Sale	10,000	13.41	$134,100.00	0	4
2024-02-09	Kolchinsky, Peter, Ra Cap…	Director,TenPercentOwner	-	Indirect	Purchase	2,557,593	10.64	$27,212,789.52	9,179,273	4
2023-11-30	Mcarthur, James G	Director,Officer	President and CEO	Direct	Purchase	1,694	4.17	$7,063.98	1,694	4
2023-06-08	Mcarthur, James G	Director,Officer	President and CEO	Direct	Sale	2,381	16.04	$38,191.24	0	4
2023-06-07	Mcarthur, James G	Director,Officer	President and CEO	Direct	Sale	8,419	16.23	$136,640.37	0	4
2023-06-05	Mcarthur, James G	Director,Officer	President and CEO	Direct	Sale	500	16.06	$8,030.00	0	4
Additional insider transactions are for subscribers only. Unlock the complete Form 4 filing history Start 7-day free trial

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Institutional Ownership

No data available for chart

2026-03-31

80.19%

Inst. Shares: 55,405,578

Shares Outstanding: 69,091,100

2025-12-31

135.71%

Inst. Shares: 57,299,835

Shares Outstanding: 42,221,808

2025-09-30

164.51%

Inst. Shares: 56,530,408

Shares Outstanding: 34,362,876

2025-06-30

70.91%

Inst. Shares: 23,222,068

Shares Outstanding: 32,748,646

2025-03-31

77.16%

Inst. Shares: 25,212,543

Shares Outstanding: 32,674,720

Date	Institutional Shares Owned	Shares Outstanding	Institutional Ownership %
2026-03-31	55,405,578	69,091,100	80.19%
2025-12-31	57,299,835	42,221,808	135.71%
2025-09-30	56,530,408	34,362,876	164.51%
2025-06-30	23,222,068	32,748,646	70.91%
2025-03-31	25,212,543	32,674,720	77.16%
2024-12-31	24,941,350	31,583,073	78.97%
2024-09-30	25,297,002	32,581,542	77.64%
2024-06-30	25,136,386	32,469,187	77.42%
2024-03-31	24,666,823	28,656,401	86.08%
2023-12-31	16,179,315	23,796,000	67.99%
2023-09-30	16,600,342	23,790,430	69.78%
2023-06-30	17,065,811	23,790,430	71.73%
Additional institutional holders are for subscribers only. Unlock the complete Form 13F ownership history Start 7-day free trial

PepGen Inc. (PEPG) — SEC Financial Statements & Analysis

PepGen Inc. (PEPG) is a pharmaceutical preparations company, incorporated in DE. PepGen Inc. trades on Nasdaq as: PEPG. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), PepGen Inc. reported a Debt-to-Equity ratio of 0.18x, a Price-to-Book (P/B) ratio of 1.04x (TTM), at a market cap of $124.56M. Figures below are sourced from SEC EDGAR, as-filed.

Debt To Equity: 0.18x
P/B TTM: 1.04x
Market Cap: $124.56M

Data as of 2026-06-30 · Source: SEC EDGAR

Frequently Asked Questions

What industry is PepGen Inc. in?

PepGen Inc. (PEPG) operates in the Pharmaceutical Preparations industry.

What is PEPG's market cap?

PepGen Inc. (PEPG) has a market capitalization of $124.56M as of 2026-06-30.

What exchange does PEPG trade on?

PepGen Inc. (PEPG) trades on the Nasdaq.

Where is PepGen Inc. incorporated?

PepGen Inc. is incorporated in DE.

PepGen Inc.

Financial Statements

Custom Table

Interactive Financial Visualizations

Earnings Market Reaction

Performance and Valuation Metrics

Insider Transactions

Institutional Ownership

PepGen Inc. (PEPG) — SEC Financial Statements & Analysis

Frequently Asked Questions

Companies in Pharmaceutical Preparations

Wall Street's data.
Main Street's price.

PepGen Inc. (PEPG) — SEC Financial Statements & Analysis

Frequently Asked Questions

Companies in Pharmaceutical Preparations

Wall Street's data.Main Street's price.

Wall Street's data.
Main Street's price.